← Leaderboards
Danny Khalil
Sloan-Kettering Inst Can Research
$1,315,170
Attributed
$1,315,170
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $263K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,315,170 · 1
By mechanism
K08$1,315,170 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Robert V Farese$28,829,369
- Tobias C Walther$8,345,398
- Craig B Thompson$56,520,903
- Michael Stephen Glickman$43,477,930
- Michael H. Overholtzer$11,387,854
Others in their field
Other Emerging Leaders on “Adaptive Immunity”
- Yunda Huang · Fred Hutchinson Cancer Center$60,648,445
- Scott Hensley · University Of Pennsylvania$49,663,739
- S. Mark Tompkins · University Of Georgia$21,225,203
- Walter Orenstein · Emory University$16,408,221
- Gary Fanger · Rise Therapeutics, Llc$15,943,988
- Andrew Pekosz · Johns Hopkins University$14,871,138
Research focus
Adaptive ImmunityClinical TrialsAffectAgonistAnimalsAdaptive Immune ResponseAntigen-Presenting CellsAntitumor ResponseAreaAttentionAttenuatedBilateralBioinformaticsAdvisory CommitteesBlocking AntibodiesCancer ImmunotherapyCancer ModelCancer PatientCancer TypeCareerCellsCellular BiologyClinical ResearchCytokine
Grant awards (5)
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity$263,034
K08 · FY2024 · CA · contact PI
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity$263,034
K08 · FY2023 · CA · contact PI
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity$263,034
K08 · FY2022 · CA · contact PI
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity$263,034
K08 · FY2021 · CA · contact PI
Local blockade of IL10R on innate immune cells to mediate both innate and adaptive anti-tumor immunity$263,034
K08 · FY2020 · CA · contact PI